Real-time enrollment status for this b acute lymphoblastic leukemia, philadelphia chromosome negative clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:50 AM UTC
| NCT Number | NCT03739814 |
| Recruiting Status | Recruiting |
| Condition | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative |
| Phase | Clinical Trial |
| Target Enrollment | 84 participants |
| Active Locations | 275 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 6, 2026 (1 week ago) |
As of July 13, 2026: Clinical trial NCT03739814 is currently recruiting participants. This clinical trial study for b acute lymphoblastic leukemia, philadelphia chromosome negative is actively seeking new participants at 275 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03739814 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 275 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03739814 was last updated 1 week ago (July 6, 2026). HelloStudys verifies this status automatically.